AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

The MRI shows a brain tumor in an inauspicious location, and a brain biopsy will entail high risks for a patient who had ...

Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer ... It is using a subscription-based ...

[19] In general, examination with toluidine blue is associated with low specificity, and this has prevented toluidine blue from becoming a standard component of early oral cancer detection efforts ...

at ultra-low concentrations by using single-molecule counting. Perachino et al. discuss screening through the use of liquid biopsy for early cancer detection. They emphasize the need for ...